EUVIMEDEUVIMED entdecken
CrossrefInfokarte

SIRT3 Activation by SGLT2 Inhibitor Mitigates Endothelial-To-Mesenchymal Transition in Dahl Salt-Sensitive Rats Induced by High-Salt Diet

Xiu-Heng Wang, Jia-Yang Yang, Zheng-Wen Lei, Xue-Ting Zheng, Hui-Yi Xie, Hong Huang, Hui-Fang Tang, Yue Zhao, Zhi-Sheng Jiang, Heng-Jing Hu

American Journal of Hypertension · 2026-04-01 · 39 (4) · 578-585

DOI: 10.1093/ajh/hpaf209 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Salt-sensitive hypertension (SSHT) is associated with reduced expression of SIRT3 and promotes endothelial–mesenchymal transition (EndMT). Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin (DAPA), have been shown to ameliorate high-salt-induced hypertension. We hypothesized that DAPA attenuate SSHT-induced EndMT and reduce myocardial fibrosis by upregulating SIRT3 expression. This study aims to provide new insights into the mechanisms underlying the cardioprotective effects of SGLT2 inhibitors in hypertension. Methods Seven-week-old male Dahl salt-sensitive rats were fed either a high-salt diet (8% NaCl; HSD group), a normal-salt diet (0.3% NaCl; NSD group), or an HSD supplemented with DAPA (2 mg/kg/day administered via drinking water). Systolic blood pressure (SBP) was measured, and left atrial tissue was examined for fibrosis and the expression of SIRT3 and EndMT-related markers, including CD31, Snail, FSP1, Twist, VE-cadherin, and α-SMA. Results Compared with the NSD group, the HSD group exhibited increased SBP, left atrial end-systolic volume index (LAESVI), incidence and duration of atrial fibrillation (AF), and atrial fibrosis. Expression of α-SMA, Snail, FSP1, and Twist was elevated, while SIRT3, CD31, and VE-cadherin expression were decreased, along with reduced left atrial ejection fraction and left atrial function index. DAPA treatment reversed these changes. Conclusions Our findings indicate that a high-salt diet decreases SIRT3 expression, induces EndMT, and promotes myocardial fibrosis in SSHT rats. DAPA mitigates high-salt-induced EndMT and fibrosis-related AF by upregulating SIRT3, suggesting a potential mechanism for the cardioprotective effects of SGLT2 inhibitors in SSHT.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →